Investigación
Consumer Health Care está desempeñando un papel cada vez más importante en nuestra vida cotidiana. No es sólo que esté aumentando
el número de personas que consumen medicamentos sin receta para el tratamiento de afecciones moderadas - tales como tos y
resfriado, trastornos del estómago, dolor de cabeza y fatiga - sino que también se está intensificando la automedicación con
el fin de tener un cuerpo sano y fuerte.
Hemos ido creciendo de forma dramática durante los últimos cinco años y nuestra meta es ofrecer a nuestros consumidores preparados innovadores para la automedicación con el fin de mejorar su calidad de vida.
Nuestros productos y nuestra visión son globales.
Disponemos de un amplio y prestigioso surtido de productos para el cuidado de la salud: desde vitaminas, complementos minerales,
preparados de origen vegetal y marino, hasta los acreditados productos contra la tos y enfermedades por enfriamiento en todo
el mundo.
Todos estos productos reflejan nuestro compromiso con el cuidado de la salud. Nuestro objetivo es mejorar la calidad de vida
por medio de preparados que ayuden a compensar y soportar mejor el estrés y las prisas con las que nos vemos confrontados
diariamente.
En México destacan:
• Sedalmerck, analgésico de fórmula eficaz contra el dolor de cabeza.
• Diabion, única fórmula balanceada para el paciente diabético que ayuda a prevenir y retrasar las complicaciones propias de ese padecimiento.
• Iliadin, descongestivo nasal con acción rápida y prolongada.
Technological strength to tackle diverse targetsMerck Serono research brings a balance of small molecules, proteins and monoclonal antibodies into the early clinical development
pipeline. A broad base of technological expertise allows us to exploit the full potential of the biological and chemical spheres.
The application of new technologies and a broader platform of therapeutic molecules, enhanced by combined experience, is a
key factor for innovation.
Our integrated drug discovery process allows a disease-oriented approach, selecting the therapeutic method best suited to
treat that disease. Our objective is to bring the best compound to the clinic by a clear Proof-of-Concept strategic approach
in order to obtain a confirmed mode of action on patients.
Our research strategy is also supported by strong portfolio and business development from the discovery phase. Our network
of alliances with other biotech companies and academic groups fosters a constant flow of innovations into the organization
by enriching our disease knowledge and technological capabilities.
Drug discovery guided by therapeutic needsOur strong Therapeutic Area-focused drug discovery and development process includes specific disease-related scientific and
experimental expertise. A profound understanding of specific disease pathophysiology and related models is essential for successful
drug discovery.
In Oncology, our goal is to develop novel therapies that specifically target cancer cells and are more tolerable for patients.
Our research is focused on all aspects of disease pharmacology in the Oncology area with the ultimate goal to increase patient
survival and improve quality of life.
We focus on all aspects of disease biology and pharmacology research in the Neurodegenerative, Autoimmune and Inflammatory
(including dermatological) disease areas with the goal to identify novel therapies that provide symptomatic relief and improve
quality of life, slow or stop disease progression.
In Fertility, we are building a portfolio of therapeutic proteins and technologies for improving convenience and success rates
for patients undergoing in vitro fertilization.
